Showing results (1-10 of 1,757) with videos related to

Sort By:
Pageof 176
Current Genomics|March 14, 2022
Quantitative Trait Loci Identification by Estimating the Genetic Model based on the Extremal SamplesZining Yang, Yaning Yang, Xu Steven Xu, et al.
Genetica|September 4, 2021
Fast and efficient correction for population stratification in multi-locus genome-wide association studiesRui Liu, Min Yuan, Xu Steven Xu, et al.
JCO Precision Oncology|July 8, 2024
Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer After Immunotherapy Through Machine Learning of Circulating Tumor DNAHaolun Ding, Xu Steven Xu, Yaning Yang, et al.
NPJ Precision Oncology|January 8, 2025
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Nature Communications|August 10, 2024
Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Computational Biology and Chemistry|January 14, 2024
MESBC: A novel mutually exclusive spectral biclustering method for cancer subtypingFengrong Liu, Yaning Yang, Xu Steven Xu, et al.
Computational Biology and Chemistry|May 31, 2022
Bias correction for multiple covariate analysis using empirical bayesian estimation in mixed-effects models for longitudinal dataYi Li, Yaning Yang, Xu Steven Xu, et al.
Clinical Pharmacology and Therapeutics|September 19, 2023
Evaluating Prognostic Value of Dynamics of Circulating Lactate Dehydrogenase in Colorectal Cancer Using Modeling and Machine LearningHaolun Ding, Min Yuan, Yaning Yang, et al.
Computers in Biology and Medicine|March 5, 2025
Discovery of mutations predictive of survival benefit from immunotherapy in first-line NSCLC: A retrospective machine learning study of IMpower150 liquid biopsy dataMin Yuan, Wei Feng, Haolun Ding, et al.
JTO Clinical and Research Reports|November 24, 2025
Evaluating Circulating Tumor DNA Clearance as an Early Intermediate End Point Predicting Clinical Benefit in Metastatic Nonsquamous NSCLC After First-Line ChemoimmunotherapyMin Yuan, Haolun Ding, Weiwei Zhuang, et al.
Pageof 176